Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis

Rheumatology International

Volumn 32, Issue 4, 2012, Pages 985-990

  Duan, Yuanhui ^a   Hao, Dongsheng ^a   Li, Ming ^a   Wu, Zhihong ^a   Li, Deling ^a   Yang, Xinyu ^a   Qiu, Guixing ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Biomarker; Osteoarthritis; Synovial fluid; Visfatin

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNOVIAL FLUID;

AGED; AGGRECANS; BIOLOGICAL MARKERS; CARTILAGE; COLLAGEN TYPE II; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 84863519104     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1731-8     Document Type: Article

References (37)

1. Lorenz H, Richter W (2006) Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 40(3):135-163 (Pubitemid 43833326)
2. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, Van Osch GJ, Van Offel JF, Verhaar JA et al (2010) The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage. doi:10.1016/j.joca.2010. 03.014
3. Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman B, Aliabadi P et al (1997) Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum 40(4):728-733
4. Marks R, Allegrante JP (2002) Body mass indices in patients with disabling hip osteoarthritis. Arthritis Res 4(2):112-116 (Pubitemid 34257344)
5. Manek NJ, Hart D, Spector TD, MacGregor AJ (2003) The association of body mass index and osteoarthritis of the knee joint: an examination of genetic and environmental influences. Arthritis Rheum 48(4):1024-1029 (Pubitemid 36418244)
6. Presle N, Pottie P, Dumond H, Guillaume C, Lapicque F, Pallu S et al (2006) Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage 14(7):690-695 (Pubitemid 43842733)
7. Ushiyama T, Chano T, Inoue K, Matsusue Y (2003) Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis 62(2):108-112 (Pubitemid 36135384)
8. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6):2548-2556 (Pubitemid 38766330)
9. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P et al (2003) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48(11):3118-3129 (Pubitemid 37409323)
10. Ku JH, Lee CK, Joo BS, An BM, Choi SH, Wang TH et al (2009) Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clin Rheumatol 28(12):1431-1435
11. Schäffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Schölmerich J et al (2003) Adipocytokines in synovial fluid. JAMA 290(13):1709-1710
12. Trujillo ME, Scherer PE (2005) Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257(2):167-175 (Pubitemid 40193966)
13. Senolt L, Pavelka K, Housa D, Haluzik M (2006) Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 35(5-6):247-252 (Pubitemid 44827741)
14. Hao D, Li M, Wu Z, Duan Y, Li D, Qiu G (2010) Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis. Rheumatol Int. doi:10.1007/ s00296-010-1516-0
15. Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, Galli M et al (2008) Pharmacological inhibition of nicotinamide phosphoribosyltransferase/ visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 3(5):e2267
16. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307(5708):426-430 (Pubitemid 40139988)
17. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ et al (2006) Elevated plasma level of visfatin/pre-B cell colonyenhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91(1):295-299 (Pubitemid 43069152)
18. Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A et al (2008) Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med 19(6):406-412
19. Moschen AR, Geiger S, Gerner R, Tilg H (2009) Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation- related bone disease. Mutat Res Fundam Mol Mech Mutagen. doi:10.1016/j.mrfmmm.2009.06.012
20. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178(3):1748-1758 (Pubitemid 46154646)
21. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60(7):1906-1914
22. Gosset M, Berenbaum F, Salvat C, Sautet A, Pigenet A, Tahiri K et al (2008) Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 58(5):1399-1409 (Pubitemid 351705929)
23. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494-502
24. Wang B, Chen P, Jensen AC, Karsdal MA, Madsen SH, Sondergaard BC et al (2009) Suppression of MMP activity in bovine cartilage explants cultures has little if any effect on the release of aggrecanase-derived aggrecan fragments. BMC Res Notes. doi: 10.1186/1756-0500-2-259
25. Chen WP, Bao JP, Feng J, Hu PF, Shi ZL and Wu LD (2010) Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis. Clin Chem Lab Med. doi:10.1515/cclm.2010.230
26. Toussirot E, Streit G, Wendling D (2007) The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 14(10):1095-1100 (Pubitemid 46672628)
27. Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S et al (2007) Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 56(9):2829-2839 (Pubitemid 47502729)
28. Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T et al (2003) Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 48(11):3085-3095 (Pubitemid 37409319)
29. Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM et al (2007) Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. J Clin Invest 117(6):1627-1636 (Pubitemid 46871347)
30. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14(2):1431-1437
31. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD et al (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113(9):1318-1327 (Pubitemid 39069931)
32. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M et al (2005) Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185(3):R1-R8 (Pubitemid 40883404)
33. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M et al (2005) Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289(4):E586-E590 (Pubitemid 41356079)
34. Bae SK, Kim SR, Kim JG, Kim JY, Koo TH, Jang HO et al (2006) Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett 580(17): 4105-4113 (Pubitemid 44037574)
35. McGlothlin JR, Gao L, Lavoie T, Simon BA, Easley RB, Ma SF et al (2005) Molecular cloning and characterization of canine pre- B-cell colony-enhancing factor. Biochem Genet 43(3-4):127-141 (Pubitemid 40543710)
36. Luk T, Malam Z, Marshall JC (2008) Pre-B cell colonyenhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83(4):804-816 (Pubitemid 351959859)
37. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65(9):1198-1201 (Pubitemid 44277396)